IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
14 hedge funds and large institutions have $2.71M invested in Interpace Biosciences, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
-4
Holders Change %
-22.22%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$63.9K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$2K |
| 3 |
BlackRock
New York
|
+$732 |
| 4 |
Morgan Stanley
New York
|
+$355 |
| 5 |
LCC
Lincoln Capital Corp
East Greenwich,
Rhode Island
|
+$304 |
